Medical News

RSS

New clinical chemistry analyzer highlighted by EKF Diagnostics at Arab Health 2016

EKF, will be highlighting its new Altair 240 clinical chemistry analyzer alongside many of its other POC and lab diagnostics products.

From EKF Diagnostics 21 Jan 2016

Champions Oncology begins prospective correlative trial of PDX in patients with sarcoma

Champions Oncology today announced that it has initiated a sponsored prospective correlative trial of patient derived xenograft modeling (PDX or Champions TumorGraft PDX models) in patients with metastatic or recurrent sarcoma. Mount Sinai Hospital in Toronto, Canada is the first clinical site to enroll patients in the newly-opened study.

21 Jan 2016

Oxeia accelerating development of neurometabolic treatments for concussions

Oxeia Biopharmaceuticals, Inc., a biotechnology company, is catalyzing the development of first-in-class neurometabolic treatments for concussions and other aspects of brain injury.

21 Jan 2016

MDxHealth recognized with 2015 Global Frost & Sullivan Award for Technology Innovation

Based on its recent analysis of the prostate cancer diagnostics market, Frost & Sullivan recognizes MDxHealth with the 2015 Global Frost & Sullivan Award for Technology Innovation. To advance molecular diagnostic tests for urological cancers, MDxHealth supplemented its prostate cancer test, ConfirmMDx, with a urine-based "liquid-biopsy" test called SelectMDx.

21 Jan 2016

Paradigm, UnitedHealthcare sign contractual agreement for coverage of PCDx

Paradigm, a molecular information & Next Generation Sequencing corporation specializing in providing testing for cancer patients today announced that it has entered into a contractual agreement with UnitedHealthcare for coverage of PCDx.

21 Jan 2016

FDA approves Allergan's sNDA to update label for DALVANCE (dalbavancin) for injection

Allergan plc, a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration has approved the company's supplemental new drug application (sNDA) to update the label for DALVANCE (dalbavancin) for injection.

21 Jan 2016

AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE technology

Halozyme Therapeutics, Inc. today announced that AbbVie has dosed the first subject in a clinical trial evaluating the safety and pharmacokinetics of adalimumab with Halozyme's proprietary ENHANZE technology.

21 Jan 2016

MD Anderson and AbbVie join forces to design new immunotherapy cancer patients

The immunotherapy platform at The University of Texas MD Anderson Cancer Center and the global biopharmaceutical company AbbVie will join forces to find new ways to unleash the immune system's potential to fight cancer.

21 Jan 2016

Centinel Spine reports FDA clearance and first surgical implantation of ALTOS system

Centinel Spine, Inc., announces the U.S. Food and Drug Administration clearance of ALTOS, a posterior cervical thoracic stabilization system indicated for use in either the lateral masses of the cervical spine or the pedicles of the cervical-thoracic spine. The first surgical implantation of the ALTOS system was performed by Gery Hsu, MD, CRMC Medical Associates, Coffeyville, KS on January 4, 2016.

21 Jan 2016

Singularity University, BD establish collaborative relationship to tackle global healthcare challenges

Singularity University, a benefit corporation focused on empowering leaders to leverage exponentially growing technologies to tackle the world's greatest challenges, and BD (Becton, Dickinson and Company), a leading global medical technology company, have established a collaborative relationship where BD will leverage SU's expertise, innovation space, tools and inspiration to create new growth opportunities for healthcare and BD.

21 Jan 2016

Migraines heat up as women near menopause

Migraine headaches heat up as women approach menopause, according to a new study from researchers at the University of Cincinnati, Montefiore Headache Center, Albert Einstein College of Medicine and Vedanta Research.

21 Jan 2016

Philogen launches Phase III pivotal trial in patients with Stage IIIB/C melanoma

Philogen S.p.A. today announced the launch of a pivotal trial in patients with Stage IIIB/C melanoma, following promising results obtained in a Phase II study with an innovative immunotherapeutic approach.

21 Jan 2016

A Thai man with Zika virus has been hospitalized in Taiwan

A man from Thailand has been hospitalized in Taiwan after having arrived there infected with Zika virus, an agent thought to be associated with brain-damaging birth defects in infants.

21 Jan 2016

Lilly receives FDA approval for Humulin R U-500 KwikPen

The U.S. Food and Drug Administration has approved Eli Lilly and Company's Humulin R U-500 KwikPen(insulin human injection) 500 units/mL, a pre-filled device containing Humulin R U-500, a highly concentrated formulation of insulin.

21 Jan 2016

Technology leader award given to Leica Microsystems

Wetzlar, Germany. The research and consulting company Frost & Sullivan has recognized Leica Microsystems’ newly acquired Optical Coherence Tomography (OCT) company Bioptigen of Morrisville, North Carolina, USA, as a technology leader and pioneer of the North American ophthalmic imaging industry.

From Leica Microsystems GmbH 21 Jan 2016

Allergan announces publication of VIBERZI Phase III trial results in The New England Journal of Medicine

Allergan plc announced today the publication of the positive results of the Phase III trials of VIBERZITM C IV (eluxadoline) for the treatment of irritable bowel syndrome with diarrhea (IBS-D) in the January 21 issue of The New England Journal of Medicine.

21 Jan 2016

Parental support programmes could promote healthy eating behaviours in obese children

Parental support programmes in areas with the greatest needs can have a positive effect on the consumption of unhealthy food and drink and on weight increases in obese children. This according to a randomised study conducted by Karolinska Institutet and the Stockholm County Council, Sweden, published in the International Journal of Behavioural Nutrition and Physical Activity.

21 Jan 2016

Findings may explain why type 2 diabetic patients experience smelling problems

In a study in type 2 diabetic rats, researchers at the Karolinska Institutet have identified alterations in specific nerve cells that are important for odor identification. The findings might explain why type 2 diabetic patients often experience smelling problems and potentially open up a new research field to develop preventive therapies against neurodegenerative diseases in type 2 diabetic patients.

21 Jan 2016

Psychological techniques help reduce body dissatisfaction in women with bulimia nervosa

Researchers from the University of Granada have proven that there are two psychological techniques that help reducing body dissatisfaction and its associated symptoms in women with bulimia nervosa, both of them based in the exposure of their bodies in a mirror.

21 Jan 2016

Research sheds light on mechanism by which hemangioblasts become blood cells

A research group led by Lecturer Makoto Kobayashi of the University of Tsukuba Faculty of Medicine, has managed to shed light on the puzzling mechanism by which hemangioblasts become blood cells. Although hemangioblasts are the common precursor cells for blood cells and vascular endothelia that are present during the fetal period, the discovery of hemangioblasts in adult organisms has begun to garner attention from the medical world.

21 Jan 2016

Medical News

New clinical chemistry analyzer highlighted by EKF Diagnostics at Arab Health 2016

Champions Oncology begins prospective correlative trial of PDX in patients with sarcoma

Oxeia accelerating development of neurometabolic treatments for concussions

MDxHealth recognized with 2015 Global Frost & Sullivan Award for Technology Innovation

Paradigm, UnitedHealthcare sign contractual agreement for coverage of PCDx

FDA approves Allergan's sNDA to update label for DALVANCE (dalbavancin) for injection

AbbVie doses first subject in adalimumab clinical trial using Halozyme's ENHANZE technology

MD Anderson and AbbVie join forces to design new immunotherapy cancer patients

Centinel Spine reports FDA clearance and first surgical implantation of ALTOS system

Singularity University, BD establish collaborative relationship to tackle global healthcare challenges

Migraines heat up as women near menopause

Philogen launches Phase III pivotal trial in patients with Stage IIIB/C melanoma

A Thai man with Zika virus has been hospitalized in Taiwan

Lilly receives FDA approval for Humulin R U-500 KwikPen

Technology leader award given to Leica Microsystems

Allergan announces publication of VIBERZI Phase III trial results in The New England Journal of Medicine

Parental support programmes could promote healthy eating behaviours in obese children

Findings may explain why type 2 diabetic patients experience smelling problems

Psychological techniques help reduce body dissatisfaction in women with bulimia nervosa

Research sheds light on mechanism by which hemangioblasts become blood cells

How real-time off-gas analysis improves fermentation process control

Advancing Drug Safety Assessment With AI, Predictive Modeling, and Human-Relevant Data

AI-powered analytics and experimental validation

Latest News